View in EDS HTML Full Text PDF Full Text

Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value.

Saved in:
Bibliographic Details
Title: Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value.
Authors: Reduzzi C; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY 10021, USA., Nicolò E; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY 10021, USA., Gerratana L; Department of Medicine, University of Udine, Udine 33100, Italy.; Department of Medical Oncology, CRO Aviano, National Cancer Institute, IRCCS, Aviano 33081, Italy., Ozimski LL; Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich 8049, Switzerland., Silvestri M; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Zhang Y; Department of Medicine, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA., Scholten D; Department of Medicine, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA., Serafini MS; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY 10021, USA., Manai M; Department of Medicine, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.; Pasteur Institute of Tunis, University of Tunis El Manar, Tunis 1002, Tunisia., D'Amico P; Department of Medicine, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA., Molteni E; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY 10021, USA.; Department of Medicine, University of Udine, Udine 33100, Italy., Bayou N; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY 10021, USA., Pastò B; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY 10021, USA.; Department of Medicine, University of Udine, Udine 33100, Italy., Saini M; Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich 8049, Switzerland., Davis AA; Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA., Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Cappelletti V; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Liu H; Department of Medicine, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.; Chan Zuckerberg Biohub Chicago, Chicago, IL 60642, USA., Gradishar WJ; Department of Medicine, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA., Aceto N; Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich 8049, Switzerland., Cristofanilli M; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY 10021, USA.
Source: Science translational medicine [Sci Transl Med] 2026 Mar 11; Vol. 18 (840), pp. eadw7698. Date of Electronic Publication: 2026 Mar 11.
Publication Type: Journal Article
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1946-6242
DOI:10.1126/scitranslmed.adw7698